Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marisa Wong Medina

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Discovery Medicine|July 1, 2010
The relationship between HMGCR genetic variation, alternative splicing, and statin efficacyMarisa Wong Medina
Trends in Cardiovascular Medicine|December 17, 2009
The role of HMGCR alternative splicing in statin efficacyMarisa Wong Medina, Ronald M Krauss
Pharmacogenetics and Genomics|January 20, 2010
PharmGKB: very important pharmacogene--HMGCRMarisa Wong Medina, Katrin Sangkuhl, Teri E Klein, et al.
Circulation|June 19, 2008
Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatinMarisa Wong Medina, Feng Gao, Weiming Ruan, et al.
Biodata Mining|December 14, 2012
Multivariate methods and software for association mapping in dose-response genome-wide association studiesChad C Brown, Tammy M Havener, Marisa Wong Medina, et al.
Pharmacological Reviews|December 30, 2009
Pharmacogenomic discovery using cell-based modelsMarleen Welsh, Lara Mangravite, Marisa Wong Medina, et al.
Circulation Research|September 17, 2011
Cardiovascular pharmacogenomicsDan M Roden, Julie A Johnson, Stephen E Kimmel, et al.
Plos One|May 12, 2011
Coordinately regulated alternative splicing of genes involved in cholesterol biosynthesis and uptakeMarisa Wong Medina, Feng Gao, Devesh Naidoo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 24, 2010
Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatinLara M Mangravite, Marisa Wong Medina, Jinrui Cui, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Discovery Medicine|July 1, 2010
The relationship between HMGCR genetic variation, alternative splicing, and statin efficacyMarisa Wong Medina
Trends in Cardiovascular Medicine|December 17, 2009
The role of HMGCR alternative splicing in statin efficacyMarisa Wong Medina, Ronald M Krauss
Pharmacogenetics and Genomics|January 20, 2010
PharmGKB: very important pharmacogene--HMGCRMarisa Wong Medina, Katrin Sangkuhl, Teri E Klein, et al.
Circulation|June 19, 2008
Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatinMarisa Wong Medina, Feng Gao, Weiming Ruan, et al.
Biodata Mining|December 14, 2012
Multivariate methods and software for association mapping in dose-response genome-wide association studiesChad C Brown, Tammy M Havener, Marisa Wong Medina, et al.
Pharmacological Reviews|December 30, 2009
Pharmacogenomic discovery using cell-based modelsMarleen Welsh, Lara Mangravite, Marisa Wong Medina, et al.
Circulation Research|September 17, 2011
Cardiovascular pharmacogenomicsDan M Roden, Julie A Johnson, Stephen E Kimmel, et al.
Plos One|May 12, 2011
Coordinately regulated alternative splicing of genes involved in cholesterol biosynthesis and uptakeMarisa Wong Medina, Feng Gao, Devesh Naidoo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 24, 2010
Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatinLara M Mangravite, Marisa Wong Medina, Jinrui Cui, et al.
Pageof 1